Ischaemic Cerebrovascular Disease
Conditions
Interventions
control group:Conventional Western medicine treatment (dual antiplatelet aggregation)
Sponsors
Dongfang Hospital Beijing University of Chinese Medicine
Eligibility
Sex/Gender
All
Age
35 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1)Consistent with the diagnosis of ischemic cerebrovascular disease and confirmed by imaging; 2) Age 35-80 years old; 3)The responsible vessel was located in ICA ECA MCA BA VA and treated by endovascular intervention; 4) Those with a proven diagnosis of qi deficiency and blood stasis after evaluation by the TCM Symptom Score Scale; 5) Pre-onset mRS score score 0-2; 6) Voluntary participation in this study and signed informed consent.
Exclusion criteria
Exclusion criteria: 1) Expected life survival 1.5; 7) Combined severe heart liver kidney and other organ damage patients pregnant women; 8) Accompanied by intracranial arteriovenous malformations that cannot be treated in advance or at the same time and may lead to life-threatening conditions for the patient such as aneurysms arteriovenous malformations and arteriovenous fistulas; 9) Accompanied by a history of mental illness and intellectual disability.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Responsible vascular restenosis rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| BI;TIMP-1;Chinese Medicine Score;HDL;Ox-LDL;TG;Apo- B;hs-CRP;HCY;LDL;mRS;FABP4;MMP-9;NLR;VEGF;NIHSS; | — |
Countries
China
Contacts
Public ContactGesheng Wang
Dongfang Hospital Beijing University of Chinese Medicine
Outcome results
None listed